azacitidine has been researched along with Bowel Diseases, Inflammatory in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Enoki, E; Hagiwara, S; Inoue, H; Kamata, K; Komeda, Y; Kono, M; Kudo, M; Matsumura, I; Minaga, K; Okamoto, A; Sakurai, T; Watanabe, T | 1 |
| Abreu, MT; Arnold, ET; Fukata, M; Hsu, D; Thomas, LS; Vamadevan, AS | 1 |
2 other study(ies) available for azacitidine and Bowel Diseases, Inflammatory
| Article | Year |
|---|---|
Induction of Complete Remission by Azacitidine in a Patient with Myelodysplastic Syndrome-Associated Inflammatory Bowel Disease.
Topics: Aged; Antimetabolites, Antineoplastic; Azacitidine; Cytokines; Down-Regulation; Humans; Inflammatory Bowel Diseases; Male; Myelodysplastic Syndromes; Remission Induction | 2018 |
Regulation of Toll-like receptor 4-associated MD-2 in intestinal epithelial cells: a comprehensive analysis.
Topics: Azacitidine; Caco-2 Cells; Cell Polarity; DNA Methylation; Humans; Hydroxamic Acids; Inflammatory Bowel Diseases; Intestinal Mucosa; Lipopolysaccharides; Lymphocyte Antigen 96; NF-kappa B; Promoter Regions, Genetic; Protein Binding; Toll-Like Receptor 4; Transcriptional Activation | 2010 |